Research that appears in the July 28 issue of the journal Neurology apparently shows that older (and less commonly used) meds used to treat epilepsy are not linked to increased risk of depression and suicide, like many news medicines are.
Researchers say that conventional epilepsy drugs such as Depacon, Depakote, Dilantin, Tegretol, and Zarontin are not linked to higher rates of depression and/or suicide, while newer ones like Keppra, Topamax, and Sabril are associated with a threefold increase in the risk of self-harm or suicidal behavior.
